Your CSV is on the way
We’ve sent your CSV file to [email protected]
Health Tech & Life Sciences Companies with Investments in H1 2024
Health Tech companies that had at least 1 private funding investment round in H1 2024
MedHub-AI
Video Analysis Diagnostics
MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. The company's algorithms can be incorporated into medical video systems to improve the decision-making process for cardiologists and other physicians.
MedHub-AI's technology uses multiple technological and big data processing methods to handle a massive amount of clinical data, both visual and textual. Its algorithms are designed to improve physicians' performance and shorten procedure times by providing a multilayered automated system that can be implemented from diagnosis through practical procedural guidance and documentation.
The company currently offers solutions for the cardiology and gastroenterology markets. MedHub-AI's AutocathFFR system is CE and AMAR approved.
MedHub-AI's technology uses multiple technological and big data processing methods to handle a massive amount of clinical data, both visual and textual. Its algorithms are designed to improve physicians' performance and shorten procedure times by providing a multilayered automated system that can be implemented from diagnosis through practical procedural guidance and documentation.
The company currently offers solutions for the cardiology and gastroenterology markets. MedHub-AI's AutocathFFR system is CE and AMAR approved.
Locations
Israel
HaHarash St 20, Tel Aviv, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
HaHarash St 20, Tel Aviv, Israel
Sensi.Ai
In-home Virtual Care Platform
Sensi.ai is an in-home virtual care agent for home health agencies and senior care providers. The Sensi platform leverages artificial intelligence to enable care agencies to offer round-the-clock services, despite the massive shortage of caregivers and regardless of the patients financial capacity to afford 24/7 care.
The Sensi platform delivers audio analytics-based insights designed to help eliminate blind spots and to provide agencies with complete visibility and transparency into each hour of care without having to rely on input from either the caregiver or the client.
Off-shift, Sensi serves as a much-needed safety net, providing seniors with both confidence and independence in a safe, monitored environment, all without compromising their privacy.
The Sensi platform delivers audio analytics-based insights designed to help eliminate blind spots and to provide agencies with complete visibility and transparency into each hour of care without having to rely on input from either the caregiver or the client.
Off-shift, Sensi serves as a much-needed safety net, providing seniors with both confidence and independence in a safe, monitored environment, all without compromising their privacy.
Locations
Israel
Derech Menachem Begin 90, Tel Aviv-Yafo, Israel
Offices Abroad
Danville, CA, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Derech Menachem Begin 90, Tel Aviv-Yafo, Israel
Offices Abroad
Danville, CA, USA
TenAces Biosciences
Molecular Glue Therapeutics
TenAces Biosciences is a biopharmaceutical company focused on the development of molecular glue therapeutics. The molecular glues are small molecules that can induce or stabilize the interaction between an E3 ligase and a target protein. This enhanced binding accelerates the tagging with ubiquitin, and subsequent removal of the target protein by the proteasome.
The company's approach, based on machine learning, 3D modeling and virtual compound screening, allows for the development of rationally designed molecular glues for a wide range of diseases.
The company's approach, based on machine learning, 3D modeling and virtual compound screening, allows for the development of rationally designed molecular glues for a wide range of diseases.
Locations
Israel
Rehovot, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Rehovot, Israel
QART Medical
3D Imaging System of Individual Sperm Cells
Quantitative Assisted Reproductive Technologies (QART) Medical is a clinical-stage company developing a solution for highly informative characterization and selection of sperm cells for in vitro fertilization (IVF).
The QART system aims to improve on the current success rates of intracytoplasmic sperm injection (ICSI) by quantitatively characterizing the morphology and contents of individual sperm cells with stain-free, real-time 3D topographic imaging, providing quantitative DNA integrity information on a cell-by-cell basis and automatically sorting a semen sample according to objective consensus criteria.
The QART system is a compact, stand-alone benchtop clinical workstation. It is based upon a built-in quantitative phase interferometric microscopy (IPM) imaging microscopy platform and has a microfluidics sorting stage, all controlled via a simple personal computer. Per ICSI cycle, a disposable cartridge containing the semen specimen is inserted into the workstation.
The QART system aims to improve on the current success rates of intracytoplasmic sperm injection (ICSI) by quantitatively characterizing the morphology and contents of individual sperm cells with stain-free, real-time 3D topographic imaging, providing quantitative DNA integrity information on a cell-by-cell basis and automatically sorting a semen sample according to objective consensus criteria.
The QART system is a compact, stand-alone benchtop clinical workstation. It is based upon a built-in quantitative phase interferometric microscopy (IPM) imaging microscopy platform and has a microfluidics sorting stage, all controlled via a simple personal computer. Per ICSI cycle, a disposable cartridge containing the semen specimen is inserted into the workstation.
Locations
Israel
Zarhin Street 10, Ra'anana, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Zarhin Street 10, Ra'anana, Israel
Sweetch
AI-Powered Hyper-Personalized Patient Engagement Platform
Sweetch ingeniously merges AI with behavioral science, empowering patients to better manage their chronic conditions.
By harnessing data gleaned from patients' smartphones and connected devices, Sweetch crafts real-time, hyper-personalized recommendations that cater to the nuances of an individual's health journey.
The solution have shown significant results – clinical outcomes, user satisfaction, and ROI. Sweetch's proprietary Just-in-Time-Adaptive-Intervention (JITAI) technology fine-tunes patient-user interactions by continuously analyzing ongoing patient context and past behavior patterns. Sweetch’s highly dynamic adaptation ensures that each patient's evolving needs are addressed in real time.
Interaction with users is intricately tailored, accounting for factors like timing, location, tone of voice, and other personalized elements. The result is an unparalleled experience that drives up engagement and retention to deliver outsized improvements in clinical outcomes and business KPIs.
By harnessing data gleaned from patients' smartphones and connected devices, Sweetch crafts real-time, hyper-personalized recommendations that cater to the nuances of an individual's health journey.
The solution have shown significant results – clinical outcomes, user satisfaction, and ROI. Sweetch's proprietary Just-in-Time-Adaptive-Intervention (JITAI) technology fine-tunes patient-user interactions by continuously analyzing ongoing patient context and past behavior patterns. Sweetch’s highly dynamic adaptation ensures that each patient's evolving needs are addressed in real time.
Interaction with users is intricately tailored, accounting for factors like timing, location, tone of voice, and other personalized elements. The result is an unparalleled experience that drives up engagement and retention to deliver outsized improvements in clinical outcomes and business KPIs.
Locations
Israel
Zeev Jabotinsky St 5, Ramat Gan, 5252006, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Zeev Jabotinsky St 5, Ramat Gan, 5252006, Israel
AISAP
Point-of-Care Assisted Diagnosis
AISAP supports clinicians using point-of-care ultrasound with real-time acquisition guidance, immediate interpretation, and multi-organ diagnoses, leading to exceptional clinical outcomes and health care efficiency.
AISAP developed POCAD, an intuitive, easy-to-use, secure cloud-based platform that provides AI-powered ultrasound diagnosis anywhere and at any time, designed to empower clinicians and connect care teams to provide immediate, efficient, and fast treatment, right at the patient's bedside.
POCAD is a deep-learning, secure, cloud-based platform that provides real-time analysis of images and data from any ultrasound device, assesses the patient’s condition, and predicts patient outcomes.
AISAP’s CARDIO AI-powered Point-of-Care Ultrasound Diagnostic Software received FDA clearance.
AISAP developed POCAD, an intuitive, easy-to-use, secure cloud-based platform that provides AI-powered ultrasound diagnosis anywhere and at any time, designed to empower clinicians and connect care teams to provide immediate, efficient, and fast treatment, right at the patient's bedside.
POCAD is a deep-learning, secure, cloud-based platform that provides real-time analysis of images and data from any ultrasound device, assesses the patient’s condition, and predicts patient outcomes.
AISAP’s CARDIO AI-powered Point-of-Care Ultrasound Diagnostic Software received FDA clearance.
Locations
Israel
Derech Sheba 2, Ramat Gan, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Derech Sheba 2, Ramat Gan, Israel
OCON Therapeutics
Spherical Intrauterine Drug Delivery Platform
OCON Therapeutics innovates, develops, manufactures, and commercializes women's health products based on its proprietary and patented intrauterine ball (IUB) platform. Made from the super-elastic alloy nitinol, the IUB is an ideal carrier of multiple drugs to the uterus for treating a variety of conditions.
In addition to its flagship product, the IUB Ballerine, OCON Therapeutics is developing a pipeline of products utilizing the IUB frame for indications including abnormal uterine bleeding, heavy menstrual bleeding, myomas and fibroids, and infertility.
In addition to its flagship product, the IUB Ballerine, OCON Therapeutics is developing a pipeline of products utilizing the IUB frame for indications including abnormal uterine bleeding, heavy menstrual bleeding, myomas and fibroids, and infertility.
Locations
Israel
HaMiktsoot Blvd 14, Modi'in-Maccabim-Re'ut, Israel
Offices Abroad
Herostrasse 12, 8048 Zrich, Switzerland
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
HaMiktsoot Blvd 14, Modi'in-Maccabim-Re'ut, Israel
Offices Abroad
Herostrasse 12, 8048 Zrich, Switzerland
Cell-Lipo
Personalized Cell Therapy
Cell-Lipo provides accessible science based regenerative stem cell solutions, improving aesthetic treatments & offering patients relief in chronic disorders.
Its technology is based in laser liposuction & stem cells isolation for enhanced fat grafting & other non aesthetics clinical applications. A single closed system, incorporating: advanced laser assisted Liposuction technology, that reduces tissue damage to both patient's skin & the collected cells, & a propitiatory, scientifically proven, mechanical stem cell separation technology. Other applications includes orthopedics: Osteoarthritis & sport injuries.
Cell-Lipo's RBs technology is integrated as a closed medical system in a patent-protected device to enable rapid, simple, sterile and cost-effective isolation of stem cells from fat tissue . This groundbreaking method, which is clean of enzymatic effects and reduces expensive treatment time, costs and regulatory overload, serves as a sustainable alternative to the current enzymatic isolation method, and has the potential to become the SVF stem cell isolation gold standard.
Its technology is based in laser liposuction & stem cells isolation for enhanced fat grafting & other non aesthetics clinical applications. A single closed system, incorporating: advanced laser assisted Liposuction technology, that reduces tissue damage to both patient's skin & the collected cells, & a propitiatory, scientifically proven, mechanical stem cell separation technology. Other applications includes orthopedics: Osteoarthritis & sport injuries.
Cell-Lipo's RBs technology is integrated as a closed medical system in a patent-protected device to enable rapid, simple, sterile and cost-effective isolation of stem cells from fat tissue . This groundbreaking method, which is clean of enzymatic effects and reduces expensive treatment time, costs and regulatory overload, serves as a sustainable alternative to the current enzymatic isolation method, and has the potential to become the SVF stem cell isolation gold standard.
Locations
Israel
HaArba'a St 28, Tel Aviv-Yafo, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
HaArba'a St 28, Tel Aviv-Yafo, Israel
Pulsar Medtech
Wearable Bone Growth Stimulators
Pulsar Medtech is revolutionizing the orthopedic world by transforming Bone Growth Stimulator (BGS) technology into wearable devices. Its mission is to improve patient outcomes and comfort by replacing traditional, bulky, and cumbersome BGS devices with a groundbreaking solution: a small, smart, and wearable electronic patch.
Traditional BGS devices are big, cumbersome and uncomfortable to wear, leading to poor patient compliance and limiting their potential in treating bone healing and fractures. These legacy devices often deter patients from using them consistently, slowing recovery and limiting the range of conditions they can effectively treat. Pulsar Medtech's innovative wearable patch offers the same proven effectiveness as traditional BGS devices, but designed to prioritize patient’s comfort. Its flagship product is the first smart, wearable BGS device, the FHP (Fracture Healing Patch).
Pulsar Medtech's innovative wearable patch offers the same proven effectiveness as traditional BGS devices, but designed to prioritize patient’s comfort. Our flagship product, the FHP (Fracture Healing Patch), is the first smart, wearable BGS device that seamlessly integrates into the patient’s lifestyle. Just place the thin electronic patch under a cast or next to the skin, and it will heal Non-union fractures, or accelerates bone the healing of any common fracture by up to 30% compared to conventional methods.
Whether treating nonunion fractures, spinal fusion, or other orthopedic conditions, Pulsar Medtech puts patient comfort at the center, ensuring higher compliance and faster, more effective recovery. The future of bone healing is no longer bulky and uncomfortable—it’s smart, discreet, and wearable.
Traditional BGS devices are big, cumbersome and uncomfortable to wear, leading to poor patient compliance and limiting their potential in treating bone healing and fractures. These legacy devices often deter patients from using them consistently, slowing recovery and limiting the range of conditions they can effectively treat. Pulsar Medtech's innovative wearable patch offers the same proven effectiveness as traditional BGS devices, but designed to prioritize patient’s comfort. Its flagship product is the first smart, wearable BGS device, the FHP (Fracture Healing Patch).
Pulsar Medtech's innovative wearable patch offers the same proven effectiveness as traditional BGS devices, but designed to prioritize patient’s comfort. Our flagship product, the FHP (Fracture Healing Patch), is the first smart, wearable BGS device that seamlessly integrates into the patient’s lifestyle. Just place the thin electronic patch under a cast or next to the skin, and it will heal Non-union fractures, or accelerates bone the healing of any common fracture by up to 30% compared to conventional methods.
Whether treating nonunion fractures, spinal fusion, or other orthopedic conditions, Pulsar Medtech puts patient comfort at the center, ensuring higher compliance and faster, more effective recovery. The future of bone healing is no longer bulky and uncomfortable—it’s smart, discreet, and wearable.
Locations
Israel
Metsada St 9, Bnei Brak, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Metsada St 9, Bnei Brak, Israel
SYNERGYM.AI
Virtual Sports Psychologist
Synergym.Ai is a Techstars alumni company (2022 batch)
Over 50% of fitness club members are quitting in the first 6 months and canceling their membership, mostly due to a struggle in maintaining motivation.
The solution is to empower trainees to maintain internal motivation to continue training, connect with the fitness club and make exercise an integral part of their daily routine.
Synergym.Ai is a psychology-based AI platform that helps fitness clubs recruit and retain clients and increase revenues by empowering trainees to maintain high motivation for exercise.
The platform includes a mobile app for the trainer, a mobile app for the trainee, and a mobile and web app for the fitness center manager.
Over 50% of fitness club members are quitting in the first 6 months and canceling their membership, mostly due to a struggle in maintaining motivation.
The solution is to empower trainees to maintain internal motivation to continue training, connect with the fitness club and make exercise an integral part of their daily routine.
Synergym.Ai is a psychology-based AI platform that helps fitness clubs recruit and retain clients and increase revenues by empowering trainees to maintain high motivation for exercise.
The platform includes a mobile app for the trainer, a mobile app for the trainee, and a mobile and web app for the fitness center manager.
Locations
Israel
Kfar Saba, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Kfar Saba, Israel
Tracells
Diagnosis of Inflammatory Bowel Diseases
Tracells specializes in non-invasive diagnostic testing for inflammatory bowel diseases (IBD) using advanced RNA transcriptomics and AI-driven classifiers. Their stool tests utilize RNA profiles from intestinal cells to accurately diagnose IBD, assess inflammation severity and location, and predict therapy response. This method aims to replace invasive procedures like endoscopies with a convenient, home-based testing alternative, offering precise, cost-effective monitoring and disease management.
Locations
Israel
Yokne'am Illit, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Yokne'am Illit, Israel
Althea Medical
Minimally Invasive Catheter-based Solution
Althea Medical is a medical device start-up company that develops a catheter-based solution for treating patients with massive and sub-massive pulmonary embolism.
The company has developed an over-the-wire novel system, which combines the efficiency of large-bore thrombectomy with an easy-to-use delivery method that minimizes patient risks, and a mechanical clot removal system used for capture and removal of all or most of the thrombus bulk.
The company has developed an over-the-wire novel system, which combines the efficiency of large-bore thrombectomy with an easy-to-use delivery method that minimizes patient risks, and a mechanical clot removal system used for capture and removal of all or most of the thrombus bulk.
Locations
Israel
Or Yehuda, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Or Yehuda, Israel
Latica Med
Improving the Female Reproductive System
Latica-Med is a medical devices company, focused on developing novel therapies designed to transform the standard of care for Gynecology and other diseases with the aim to improve women fertility by non-invasive, non-drug therapy.
Latica owns a proprietary patented Acoustic Pulse Technology (APT) device specifically designed for treating Gynecology disorders. APT as a shockwave have been widely reported over the last 20 years for treating patients with inflammatory, ischemic diseases treatment devices. Latica's APT is a compact, cost-effective device, specially designed for treatments on a large treatment area (50x350 mm), which can open an opportunity for Gynecology treatments in a short time.
Latica uses its innovative acoustic pulses technology (APT) to prepare women for the delicate IVF process, by treating most of the root-causes of infertility, including: Infections, implantation failures, endometrium thickness and Endometriosis.
The company's pre-clinical trial showed a 60% improvement in pregnanc
Latica owns a proprietary patented Acoustic Pulse Technology (APT) device specifically designed for treating Gynecology disorders. APT as a shockwave have been widely reported over the last 20 years for treating patients with inflammatory, ischemic diseases treatment devices. Latica's APT is a compact, cost-effective device, specially designed for treatments on a large treatment area (50x350 mm), which can open an opportunity for Gynecology treatments in a short time.
Latica uses its innovative acoustic pulses technology (APT) to prepare women for the delicate IVF process, by treating most of the root-causes of infertility, including: Infections, implantation failures, endometrium thickness and Endometriosis.
The company's pre-clinical trial showed a 60% improvement in pregnanc
Locations
Israel
Khayim Barlev St 21, Hod Hasharon, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Khayim Barlev St 21, Hod Hasharon, Israel
Talma Medical Diagnostics
EEG based Acute Otitis Media (AOM) Diagnostic Device
Talma Medical develops a breakthrough innovative technology for accurate clinical diagnostic at home. An over the counter, easy to use and mostly accurate device will make a revolution in the way AOM is diagnosed.
Locations
Israel
Kaufmann St 2, Tel Aviv-Yafo, 6801294, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Kaufmann St 2, Tel Aviv-Yafo, 6801294, Israel
Embie Clinic
Enabling a 10X growth in Fertility Treatments in the US via Remote Fertility Treatment
Embie is pioneering in the field of remote fertility management. Our suite of products expands fertility clinics' geographic reach and enhances their operational efficiency. Peer-reviewed research has been published on how our mobile app boosts pregnancy success rates. Our first US clinic customers are signed and set to go live in Q4 of 2024
Locations
Israel
Tel Aviv, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Tel Aviv, Israel
Scopio Labs
Computational Microscopy for Blood Diagnostics
Scopio Labs has designed and built a computational microscope and developed a proprietary diagnostics platform to enable quality microscopic analysis, with the aim of providing easy and wide access to microscopy. By merging hardware and software, the companys ultimate goal is to provide better diagnostics for everyone.
Scopio Labs smart digitized system bolsters manual examination by automating the majority of the screening process. It automatically scans the relevant area of the slide, preclassifies cells, and prepares the information for quick review in order to increase efficiency and connectivity while reducing the effects of human error. The digital microscopy solution is designed to improve overall usability, produce a platform accessible to all labs, and increase accuracy and connectivity by capturing the entire sample as opposed to individual cells.
The Full-Field Peripheral Blood Smear Application on the X100 is the first end-to-end digital solution that offers full-field imaging and an AI-powered Decision Support System (DSS) with remote connectivity through your secure hospital network. The Full-Field Peripheral Blood Smear Application (FF-PBS) on the X100 is FDA Cleared and CE Marked.
Scopio Labs smart digitized system bolsters manual examination by automating the majority of the screening process. It automatically scans the relevant area of the slide, preclassifies cells, and prepares the information for quick review in order to increase efficiency and connectivity while reducing the effects of human error. The digital microscopy solution is designed to improve overall usability, produce a platform accessible to all labs, and increase accuracy and connectivity by capturing the entire sample as opposed to individual cells.
The Full-Field Peripheral Blood Smear Application on the X100 is the first end-to-end digital solution that offers full-field imaging and an AI-powered Decision Support System (DSS) with remote connectivity through your secure hospital network. The Full-Field Peripheral Blood Smear Application (FF-PBS) on the X100 is FDA Cleared and CE Marked.
Locations
Israel
HaSharon St 10, Tel Aviv-Yafo, Israel
Offices Abroad
New Jersey, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
HaSharon St 10, Tel Aviv-Yafo, Israel
Offices Abroad
New Jersey, USA
Fairtility
AI-powered IVF Solutions
Fairtility is powering in vitro fertilization (IVF) through transparent artificial intelligence to improve outcomes. It allows to reduce the number of IVF cycles to live birth, minimize the emotional, physical and financial burden on prospective parents, and enable collaborative discussions between clinicians and patients.
CHLOE (Cultivating Human Life through Optimal Embryos) is a transparent AI-based decision support tool that provides clinicians with complete visibility into the clinical and laboratory parameters that make up data output to help improve IVF outcomes. Beginning with CHLOE EQ, a proprietary embryo grading platform, Fairtility is on a path to expand CHLOE's application to span the full IVF journey, from infertility cause assessment through transfer optimization.
CHLOE (Cultivating Human Life through Optimal Embryos) is a transparent AI-based decision support tool that provides clinicians with complete visibility into the clinical and laboratory parameters that make up data output to help improve IVF outcomes. Beginning with CHLOE EQ, a proprietary embryo grading platform, Fairtility is on a path to expand CHLOE's application to span the full IVF journey, from infertility cause assessment through transfer optimization.
Locations
Israel
HaMelacha St 8, Tel Aviv-Yafo, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
HaMelacha St 8, Tel Aviv-Yafo, Israel
EviCure
Extracellular Vesicles-based Platform for the Treatment of Cancer
EviCure is developing a novel extracellular vesicle (EV)--based platform technology for cancer treatment. EviCure leverages AI capabilities and sophisticated human cancer disease models for in-depth comparative analyses of various stem cell subpopulations and secreted EVs to achieve robust and specific anti-tumor effects against a wide range of solid tumors.
In addition to their endogenous therapeutic effects, EviCure’s EVs can be used as vehicles for the targeted delivery of RNA-based therapies, peptides, and small therapeutic molecules. This combined approach generates EVs that target multiple oncogenic pathways associated with tumor growth, metastasis, and resistance to radiation and advanced treatments.
EviCure has also developed a groundbreaking approach for the of scale up of EVs using artificial intelligence (AI) algorithms and biological sensors to produce EVs in a consistent and reproducible process maintaining their anti-tumor effects throughout the entire scale-up production.
PL-Ex-1 is the first product on EviCure’s platform and is expected to become a leading EV treatment against lung cancer providing a safe, cost-effective, mutation-agnostic, and stage-independent treatment for different types of lung and other solid tumors.
In addition to their endogenous therapeutic effects, EviCure’s EVs can be used as vehicles for the targeted delivery of RNA-based therapies, peptides, and small therapeutic molecules. This combined approach generates EVs that target multiple oncogenic pathways associated with tumor growth, metastasis, and resistance to radiation and advanced treatments.
EviCure has also developed a groundbreaking approach for the of scale up of EVs using artificial intelligence (AI) algorithms and biological sensors to produce EVs in a consistent and reproducible process maintaining their anti-tumor effects throughout the entire scale-up production.
PL-Ex-1 is the first product on EviCure’s platform and is expected to become a leading EV treatment against lung cancer providing a safe, cost-effective, mutation-agnostic, and stage-independent treatment for different types of lung and other solid tumors.
Locations
Israel
Rehovot, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Rehovot, Israel
Vessi Medical
Cryotherapy for treatment of urological tissue
Vessi Medical is developing a new approach in the treatment of urological tissue. The company treats superficial urological tissue using surface cryotherapy, utilizing extreme cold to freeze and destroy abnormal tissue.
The Vessi Medical system consists of a stand-alone console and a disposable catheter which is inserted into the bladder in a manner similar to existing intravesical techniques. Vessi's minimally invasive unique cryotherapy solution provides a therapeutic alternative to surgery while reducing the cost and complications associated with current treatments.
First in human study (FIH) clinical trial was finalized (2023) , with very promising results.
The Vessi Medical system consists of a stand-alone console and a disposable catheter which is inserted into the bladder in a manner similar to existing intravesical techniques. Vessi's minimally invasive unique cryotherapy solution provides a therapeutic alternative to surgery while reducing the cost and complications associated with current treatments.
First in human study (FIH) clinical trial was finalized (2023) , with very promising results.
Locations
Israel
Misgav, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Misgav, Israel
Ark Surgical
Commercial-stage medical device company in the field of women`s health, with 2 FDA-cleared devices.
Ark Surgical is a commercial-stage medical device company focused on advancing women’s health through safer, smarter surgical solutions.
The company has successfully addressed a critical unmet need identified by the FDA and now offers two FDA-cleared devices in the U.S. market.
Its flagship product, LapBox, is a first-of-its-kind containment system that enables minimally invasive and robotic gynecologic surgeries while preventing the spread of cancerous or endometrial tissue—a risk highlighted by the FDA.
Ark Surgical’s technology empowers gynecologic surgeons to optimize outcomes and patient safety while helping hospitals meet FDA compliance standards for tissue containment.
The company has successfully addressed a critical unmet need identified by the FDA and now offers two FDA-cleared devices in the U.S. market.
Its flagship product, LapBox, is a first-of-its-kind containment system that enables minimally invasive and robotic gynecologic surgeries while preventing the spread of cancerous or endometrial tissue—a risk highlighted by the FDA.
Ark Surgical’s technology empowers gynecologic surgeons to optimize outcomes and patient safety while helping hospitals meet FDA compliance standards for tissue containment.
Locations
Israel
Wadi el-Haj Street 13, Nazareth, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Wadi el-Haj Street 13, Nazareth, Israel
Emet Surgical
Transforming Minimally Invasive Surgery from Experience Dependent to Data Enhanced
Emet Surgical is redefining minimally invasive surgery with ESP – the Enhanced Surgical Precision system, an AI/ML-powered platform that provides real-time surgical guidance and cancerous tissue recognition. Founded by cancer survivor and tech entrepreneur Bob Witkow, and developed in consultation with experienced surgeons, ESP supports—rather than replaces—surgeons’ expertise. It delivers real-time, data-driven insights on the surgical video feed, enhancing precision and decision-making.
Emet Surgical helps surgeons reduce complications and reoperations—persistent challenges despite decades of progress in surgical tools and techniques. The company also aims to reverse the measurable decline in incidental cancer detection since the shift from open to minimally invasive surgery. By improving visibility of critical structures and suspicious tissue in real time, ESP can improve outcomes and lower treatment costs.
ESP works with any robotic or laparoscopic system and runs on proprietary technology, including IP developed internally and licensed from the University of Minnesota. Foundational research, funded largely by the U.S. National Science Foundation, gives Emet Surgical a deep scientific base with strong capital efficiency. ESP recently reached a milestone by identifying cancerous tissue in real time during video analysis—a key step toward clinical trials.
Emet Surgical will launch ESP with cancer recognition, followed by advanced dissection guidance and hospital system integration. Regulatory submissions for FDA 510(k) SaMD, EU CE Mark, UKCA, and Israel AMAR are planned for Q4 2025 and Q1 2026.
The company is raising capital to complete validation, secure regulatory approval, and enter the market. Investors in AI, surgical robotics, or digital health are invited to connect.
Emet Surgical operates under the legal entities Emet Surgical Inc. (USA) and Emet Medical Devices Ltd. (Israel).
Emet Surgical helps surgeons reduce complications and reoperations—persistent challenges despite decades of progress in surgical tools and techniques. The company also aims to reverse the measurable decline in incidental cancer detection since the shift from open to minimally invasive surgery. By improving visibility of critical structures and suspicious tissue in real time, ESP can improve outcomes and lower treatment costs.
ESP works with any robotic or laparoscopic system and runs on proprietary technology, including IP developed internally and licensed from the University of Minnesota. Foundational research, funded largely by the U.S. National Science Foundation, gives Emet Surgical a deep scientific base with strong capital efficiency. ESP recently reached a milestone by identifying cancerous tissue in real time during video analysis—a key step toward clinical trials.
Emet Surgical will launch ESP with cancer recognition, followed by advanced dissection guidance and hospital system integration. Regulatory submissions for FDA 510(k) SaMD, EU CE Mark, UKCA, and Israel AMAR are planned for Q4 2025 and Q1 2026.
The company is raising capital to complete validation, secure regulatory approval, and enter the market. Investors in AI, surgical robotics, or digital health are invited to connect.
Emet Surgical operates under the legal entities Emet Surgical Inc. (USA) and Emet Medical Devices Ltd. (Israel).
Locations
Israel
Derech Menachem Begin 146, Tel Aviv-Yafo, Israel
Offices Abroad
1660 S Albion St suite 315, Denver, CO 80222, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Derech Menachem Begin 146, Tel Aviv-Yafo, Israel
Offices Abroad
1660 S Albion St suite 315, Denver, CO 80222, USA
Nucleai
Spatial Biology Software Platform for Precision Medicine
Nucleai’s technology leverages intelligence-grade geospatial AI methods to analyze and interpret complex cellular interactions in a patient’s biopsy, translating them into actionable insights that can accelerate the development of life-saving treatments and diagnostics.
The company deploys an AI spatial tool for patient selection in a clinical trial, in partnership with a top 10 biopharma company. The platform pioneers AI-driven spatial biomarker analysis, offering a first-of-its-kind multimodal solution. It ingests images from various modalities (H&E, IHC, and multiplex immunofluorescence), conducts advanced spatial analysis, and delivers actionable insights. These insights empower pathologists and researchers with an AI-powered data-rich action plan, paving the way for more informed decisions in the development of next-generation treatments such as bi-specifics, antibody-drug conjugates (ADCs), and immunotherapy.
Nucleai is working with more than 60 percent of the Top 20 biopharma companies in the world, and has an ecosystem of partners across diagnostics, contract research organizations (CROs), and life sciences tools companies.
The company deploys an AI spatial tool for patient selection in a clinical trial, in partnership with a top 10 biopharma company. The platform pioneers AI-driven spatial biomarker analysis, offering a first-of-its-kind multimodal solution. It ingests images from various modalities (H&E, IHC, and multiplex immunofluorescence), conducts advanced spatial analysis, and delivers actionable insights. These insights empower pathologists and researchers with an AI-powered data-rich action plan, paving the way for more informed decisions in the development of next-generation treatments such as bi-specifics, antibody-drug conjugates (ADCs), and immunotherapy.
Nucleai is working with more than 60 percent of the Top 20 biopharma companies in the world, and has an ecosystem of partners across diagnostics, contract research organizations (CROs), and life sciences tools companies.
Locations
Israel
Ein Zeitim St 4, Tel Aviv-Yafo, Israel
Offices Abroad
1375 W Fulton St, Chicago, IL 60607, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Ein Zeitim St 4, Tel Aviv-Yafo, Israel
Offices Abroad
1375 W Fulton St, Chicago, IL 60607, USA
Nurami Medical
Modernizing Soft Tissue Repair
Nurami harnesses nanofibers and novel biomaterials to modernize soft tissue surgical repair.
Nurami’s proprietary, electrospun-based platform technology enables the creation of an innovative category of bio surgical implants to seal and heal wounds effectively. These advanced products address complications associated with current soft tissue implants, such as dangerous leaks, and promote healthy tissue formation such as Dura repair as well as other tissue recovery processes.
Nurami's first soft-tissue repair product, ArtiFascia, is a multilayer, Dural repair graft made of biocompatible and bioabsorbable polymers with integrated barrier layer and a biomimetic structure of electrospun fibers designed to promote neodura regeneration. ArtiFascia is available for commercial use in the USA and has FDA 510(k) clearance.
Nurami’s proprietary, electrospun-based platform technology enables the creation of an innovative category of bio surgical implants to seal and heal wounds effectively. These advanced products address complications associated with current soft tissue implants, such as dangerous leaks, and promote healthy tissue formation such as Dura repair as well as other tissue recovery processes.
Nurami's first soft-tissue repair product, ArtiFascia, is a multilayer, Dural repair graft made of biocompatible and bioabsorbable polymers with integrated barrier layer and a biomimetic structure of electrospun fibers designed to promote neodura regeneration. ArtiFascia is available for commercial use in the USA and has FDA 510(k) clearance.
Locations
Israel
Ha-Namal Street 36, Haifa, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Ha-Namal Street 36, Haifa, Israel
Evinature
Clinically proven, evidence-based nutraceuticals for gut health tailored to IBD, IBS, diverticulitis
Evinature was founded on the nexus of two medical philosophies. By bridging the gap between modern and traditional medicine, we’re able to provide more patients with safe and natural remedies that are embraced by the medical community.
We believe it’s time for healthcare to prioritize patient global accessibility to accurate medical assessments and affordable treatments. No patents, no trends, no misinformation. We simply develop, test, prove, then give back to the community.
Tailored Protocols:
No two bodies are the same, which is why we provide evidence-based protocols that address each patient’s condition and state of severity so we can precisely target your individual needs and improve long-term results.
Guided Care:
Regular online follow-ups enable precise adjustments to your protocol so we can address your changing needs throughout treatment. And to ease the way, we also provide complementary clinic support to guide you through the entire process.
Labs:
We’re constantly refining our products through ongoing research and collaborations with over 20 leading medical centers in the U.S, enabling the further development of effective neutraceuticals that are accessible to patients worldwide.
Evidence:
Evinature prioritizes evidence above the trends. We are caregivers by profession, and therefore emphasize product quality and scientific integrity above all else, exclusively distributing products that have passed the golden standard of clinical trials.
By the Patient for the Patient:
Patients are the greatest untapped resource in healthcare, which is why we’ve developed a research database founded on their invaluable experience. At Evinature, each patient contributes to the community simply by taking the assessment. This allows us to constantly expand our research and keep the community updated with vital news and information.
We believe it’s time for healthcare to prioritize patient global accessibility to accurate medical assessments and affordable treatments. No patents, no trends, no misinformation. We simply develop, test, prove, then give back to the community.
Tailored Protocols:
No two bodies are the same, which is why we provide evidence-based protocols that address each patient’s condition and state of severity so we can precisely target your individual needs and improve long-term results.
Guided Care:
Regular online follow-ups enable precise adjustments to your protocol so we can address your changing needs throughout treatment. And to ease the way, we also provide complementary clinic support to guide you through the entire process.
Labs:
We’re constantly refining our products through ongoing research and collaborations with over 20 leading medical centers in the U.S, enabling the further development of effective neutraceuticals that are accessible to patients worldwide.
Evidence:
Evinature prioritizes evidence above the trends. We are caregivers by profession, and therefore emphasize product quality and scientific integrity above all else, exclusively distributing products that have passed the golden standard of clinical trials.
By the Patient for the Patient:
Patients are the greatest untapped resource in healthcare, which is why we’ve developed a research database founded on their invaluable experience. At Evinature, each patient contributes to the community simply by taking the assessment. This allows us to constantly expand our research and keep the community updated with vital news and information.
Locations
Israel
HaMelacha St 3, Binyamina-Giv'at Ada, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
HaMelacha St 3, Binyamina-Giv'at Ada, Israel
SORLIS
Pressure Ulcers Prevention and Monitoring Platform
SORLIS is dedicated to transforming healthcare through early detection of pressure ulcers.
The company focuses on developing solutions that are both impactful and practical for healthcare providers. Its mission is to alleviate patient suffering, streamline medical staff workflows, and significantly reduce healthcare costs associated with preventable conditions. By identifying pressure injuries at their onset, Sorlis aims to set a new standard in patient care and efficiency within the healthcare system.
The company focuses on developing solutions that are both impactful and practical for healthcare providers. Its mission is to alleviate patient suffering, streamline medical staff workflows, and significantly reduce healthcare costs associated with preventable conditions. By identifying pressure injuries at their onset, Sorlis aims to set a new standard in patient care and efficiency within the healthcare system.
Locations
Israel
Haifa, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Haifa, Israel
Life Therapeutics
Precision Immunotherapies Targeting Circulating Tumor Cells
This company is a known business entity but lacks sufficient data to support a standard Finder profile.
Locations
Israel
Tel Aviv-Yafo, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Tel Aviv-Yafo, Israel
NovaSight
Eye-Tracking Based Solutions for Pediatric Vision Care
Founded in 2016, NovaSight is a growing medical device company focused on preventing vision impairments in children through eye-tracking-based technology for diagnostic, therapeutic, and preventive care.
CureSight™: NovaSight’s FDA-cleared, CE-marked, and NMPA-approved digital amblyopia treatment allows pediatric patients to receive binocular vision therapy at home while watching their favorite streamed content under remote supervision. Since launching the CureSight Referral Program in 2023 in the US and Italy, it has grown rapidly. Over 500 eye care providers (ECPs)—including top institutions like Cleveland Clinic, Seattle Children's Hospital, and Duke University—are now referring patients, leading to program availability in 42 states and ~1,700 referrals to date.
EyeSwift PRO: NovaSight’s vision diagnostics device uses eye-tracking technology to automate protocols for amblyopia monitoring, binocular vision, and other conditions. Each protocol includes relevant unitary tests and generates clear, easy-to-understand reports for operators and patients.
TrackSight™: Addressing the global myopia epidemic, NovaSight developed TrackSight, a SaaS-based myopia prevention tool for mobile devices that uses AI-driven eye tracking and real-time peripheral blur adjustments to slow myopia progression. A recent proof-of-concept study at Sheba Medical Center showed reduced axial length, a key myopia prevention marker. A larger pilot study with ~300 pre-myopic children is planned for early 2025 across China, Canada, Singapore, and Israel.
Looking Ahead: NovaSight’s 2025 focus includes advancing TrackSight’s clinical studies, global commercialization of CureSight, and closing its Round B funding by Q1 2025.
CureSight™: NovaSight’s FDA-cleared, CE-marked, and NMPA-approved digital amblyopia treatment allows pediatric patients to receive binocular vision therapy at home while watching their favorite streamed content under remote supervision. Since launching the CureSight Referral Program in 2023 in the US and Italy, it has grown rapidly. Over 500 eye care providers (ECPs)—including top institutions like Cleveland Clinic, Seattle Children's Hospital, and Duke University—are now referring patients, leading to program availability in 42 states and ~1,700 referrals to date.
EyeSwift PRO: NovaSight’s vision diagnostics device uses eye-tracking technology to automate protocols for amblyopia monitoring, binocular vision, and other conditions. Each protocol includes relevant unitary tests and generates clear, easy-to-understand reports for operators and patients.
TrackSight™: Addressing the global myopia epidemic, NovaSight developed TrackSight, a SaaS-based myopia prevention tool for mobile devices that uses AI-driven eye tracking and real-time peripheral blur adjustments to slow myopia progression. A recent proof-of-concept study at Sheba Medical Center showed reduced axial length, a key myopia prevention marker. A larger pilot study with ~300 pre-myopic children is planned for early 2025 across China, Canada, Singapore, and Israel.
Looking Ahead: NovaSight’s 2025 focus includes advancing TrackSight’s clinical studies, global commercialization of CureSight, and closing its Round B funding by Q1 2025.
Locations
Israel
Lod, Israel
Offices Abroad
Virginia, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Lod, Israel
Offices Abroad
Virginia, USA
Nanomedic Technologies
Portable Wound Treatment System
Nanomedic Technologies is a biomedical therapeutics technology company specializing in the research, development, and distribution of its innovative EHF technology and SpinCare System platform for advanced wound treatment.
Nanomedics electrospinning EHF technology biomimics the natural structure of human tissue and extracellular matrix (ECM), providing a temporary skin substitute that encourages quick and efficient tissue integration and regeneration to expedite recovery and minimize potential complications.
The SpinCare System delivers multiple benefits due to its portability and its ability to slowly release therapeutic and healing enhancing additives into the patients wound in accordance with clinical needs.
Nanomedic is a spin-off company and subsidiary of Nicast, which is developing implantable medical devices made of electrospun polymer nanofabrics. The SpinCare system is CE certified for marketing in Europe.
Nanomedics electrospinning EHF technology biomimics the natural structure of human tissue and extracellular matrix (ECM), providing a temporary skin substitute that encourages quick and efficient tissue integration and regeneration to expedite recovery and minimize potential complications.
The SpinCare System delivers multiple benefits due to its portability and its ability to slowly release therapeutic and healing enhancing additives into the patients wound in accordance with clinical needs.
Nanomedic is a spin-off company and subsidiary of Nicast, which is developing implantable medical devices made of electrospun polymer nanofabrics. The SpinCare system is CE certified for marketing in Europe.
Locations
Israel
Yodfat Street 2, Lod, Israel
Offices Abroad
Memphis, TN, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Yodfat Street 2, Lod, Israel
Offices Abroad
Memphis, TN, USA
DormoTech Medical
At-home Sleep Assessment System
DormoTech Medical is a Digital Health company, specializing in monitoring and diagnosis of sleep disorders.
DormoTech developed DormoVision X, a groundbreaking solution equipped with patented technology and FDA clearance. The system offers a comprehensive testing cycle, featuring a patient-centric device, alongside user-friendly scoring and reporting systems. Leveraging a unique machine-assisted scoring methodology, DormoVision X ensures intuitive operation and simplified analysis.
The device meets the stringent standards set by the Centers for Medicare & Medicaid Services (CMS) and the American Association of Sleep Medicine (AASM).
The company also developed DormoTech VisionPro, a comprehensive solution for sleep test analysis. With both auto and manual scoring capabilities, along with robust record management and archiving features, DormoTech Vision Pro is an all-in-one SAAS solution.
DormoTech developed DormoVision X, a groundbreaking solution equipped with patented technology and FDA clearance. The system offers a comprehensive testing cycle, featuring a patient-centric device, alongside user-friendly scoring and reporting systems. Leveraging a unique machine-assisted scoring methodology, DormoVision X ensures intuitive operation and simplified analysis.
The device meets the stringent standards set by the Centers for Medicare & Medicaid Services (CMS) and the American Association of Sleep Medicine (AASM).
The company also developed DormoTech VisionPro, a comprehensive solution for sleep test analysis. With both auto and manual scoring capabilities, along with robust record management and archiving features, DormoTech Vision Pro is an all-in-one SAAS solution.
Locations
Israel
Afula, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Afula, Israel
In-House Health
AI-driven Scheduling and Management Platform for Modern Nursing Teams
In-house Health is developing an artificial intelligence predictive scheduling and management platform for modern nursing teams in hospitals.
Locations
Israel
Israel
Offices Abroad
Denver, CO, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Israel
Offices Abroad
Denver, CO, USA
Spinodal
Disposable Robotic Catheter Sheath
Spinodal is developing the first disposable robotic catheter sheath for interventional cardiology.
Locations
Israel
Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Israel
Bionaut Labs
Precision-targeted Medicine Modality for CNS Disorders
Bionaut Labs is a biotechnology start-up focused on treating central nervous system disorders (CNS) with its Bionaut precision medicine treatment modality. Bionaut uses remote-controlled microscale robots to deliver biologics, nucleic acids, or small molecule therapies locally to targeted CNS disease areas. Through precision localized brain targeting, Bionaut therapeutics could offer better efficacy and safety that cannot be achieved by other traditional treatment modalities.
Two of the company's earliest indications are for gliomas and Huntington's disease. The Bionaut therapeutic-containing drug targets a disease similarly to how a traditional modality targets a disease. Bionauts are custom-engineered therapeutic micro-robots that target payloads to specific locations in the body. Bionauts can be constructed in different versions with custom geometries and surface characteristics. Smaller than a millimeter, they contain moving parts controlled remotely by a compact magnetic controller, allowing them to move.
Two of the company's earliest indications are for gliomas and Huntington's disease. The Bionaut therapeutic-containing drug targets a disease similarly to how a traditional modality targets a disease. Bionauts are custom-engineered therapeutic micro-robots that target payloads to specific locations in the body. Bionauts can be constructed in different versions with custom geometries and surface characteristics. Smaller than a millimeter, they contain moving parts controlled remotely by a compact magnetic controller, allowing them to move.
Locations
Israel
Arieh Shenkar Street 1, Herzliya, Israel
Offices Abroad
3767 Overland Ave, Los Angeles, CA, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Arieh Shenkar Street 1, Herzliya, Israel
Offices Abroad
3767 Overland Ave, Los Angeles, CA, USA
QuantHealth
AI-Based Clinical Trial Simulation
QuantHealth is an AI company conducting patient-centric drug simulations to accelerate and de-risk drug development.
Its AI solution enables ClinDev and ClinOps teams to holistically simulate a clinical trial in thousands of variations within minutes, allowing users to evaluate each parameter on endpoint success, commercial viability, and protocol feasibility. Its In-Silico platform generates synthetic evidence for how therapy will perform across all clinical phases, as soon as its mechanism is known, and preclinical evidence has been established. The synthetic evidence generation engine can be used to support trial planning, as well as indication selection, drug repurposing and in-licensing asset evaluation.
The company Large Healthcare Model (LHM) learns deep patient-drug interactions that drive high-resolution outcome models with 86% endpoint accuracy. Its models continually adapt as new research comes forward, and can be further enhanced with internal trial data and proprietary research.
Its AI solution enables ClinDev and ClinOps teams to holistically simulate a clinical trial in thousands of variations within minutes, allowing users to evaluate each parameter on endpoint success, commercial viability, and protocol feasibility. Its In-Silico platform generates synthetic evidence for how therapy will perform across all clinical phases, as soon as its mechanism is known, and preclinical evidence has been established. The synthetic evidence generation engine can be used to support trial planning, as well as indication selection, drug repurposing and in-licensing asset evaluation.
The company Large Healthcare Model (LHM) learns deep patient-drug interactions that drive high-resolution outcome models with 86% endpoint accuracy. Its models continually adapt as new research comes forward, and can be further enhanced with internal trial data and proprietary research.
Locations
Israel
Derech Menachem Begin 132, Tel Aviv-Jaffa, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Derech Menachem Begin 132, Tel Aviv-Jaffa, Israel
EndoCure
AI-Powered Ultrasound System for Endometriosis Diagnosis and Management
EndoCure specializes in diagnosing and managing endometriosis, which affects a significant number of women in their reproductive years. Their AI-powered ultrasound system, combined with targeted contrast agents, detects, maps, and stages endometriosis lesions. The technology includes a robotic scanning system that produces 3D images, analyzed by AI to identify lesions, enhancing diagnosis, management, and surgical planning.
Locations
Israel
Haifa, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Haifa, Israel
DOT Compliance
Compliance and Quality Management Platform
DOT Compliance offers a cloud-based native Salesforce platform for managing compliance and quality. Its product targets companies working in the areas of medical devices, pharmaceuticals, biotech, food and beverages, and other highly regulated industries.
Exceptionally customizable, DOT Compliance helps companies verify their products' suitability to industry standards. Using the platform's dashboard, companies can track and assess their lifecycle management, audit history, document revisions, training plans, electronic signatures, and more.
The company's cloud-based solution is compliant with FDA 21 CFR part 11 and is suitable for companies ranging from early-stage start-ups to enterprise-level businesses.
Exceptionally customizable, DOT Compliance helps companies verify their products' suitability to industry standards. Using the platform's dashboard, companies can track and assess their lifecycle management, audit history, document revisions, training plans, electronic signatures, and more.
The company's cloud-based solution is compliant with FDA 21 CFR part 11 and is suitable for companies ranging from early-stage start-ups to enterprise-level businesses.
Locations
Israel
Sayollo Media, Prof. Hillel ve-Khanan Oppenheimer St 2, Rehovot, Israel
Offices Abroad
2375 East Camelback Road, Phoenix, AZ, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Sayollo Media, Prof. Hillel ve-Khanan Oppenheimer St 2, Rehovot, Israel
Offices Abroad
2375 East Camelback Road, Phoenix, AZ, USA
Insightec
MR-guided Focused Ultrasound Systems
INSIGHTEC is a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy. The company's Exablate Neuro platform focuses sound waves, safely guided by MRI, to provide tremor treatment to patients with medication-refractory Essential Tremor and Parkinson's Disease.
INSIGHTEC obtained FDA approval for its technology in 2016 and 2018. Also received FDA approval and CE Mark of its Exablate Prime system. It is continuously investing in and expanding its current and investigational applications, ranging from functional neurosurgery to oncology and gynecology.
INSIGHTEC obtained FDA approval for its technology in 2016 and 2018. Also received FDA approval and CE Mark of its Exablate Prime system. It is continuously investing in and expanding its current and investigational applications, ranging from functional neurosurgery to oncology and gynecology.
Locations
Israel
Nahum Het St 5, Tirat Carmel, Israel
Offices Abroad
Dallas, TX, USA
Munich, Germany
Miami, FL, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Nahum Het St 5, Tirat Carmel, Israel
Offices Abroad
Dallas, TX, USA
Munich, Germany
Miami, FL, USA
Vortex Imaging
High-quality Medical Imaging
Vortex Imaging is developing a novel medical imaging device that has the potential to revolutionize the imaging world, saving thousands of lives annually and addressing a $120B+ market, by delivering high-quality imaging, at low cost, anywhere and at the hand of anyone.
The company is developing the world's first handheld, full volumetric (3D), operator-independent, low-cost and safe ultrasound imaging modality, based on geophysics-inspired algorithms and computational software running with GPUs on Cloud.
The company is developing the world's first handheld, full volumetric (3D), operator-independent, low-cost and safe ultrasound imaging modality, based on geophysics-inspired algorithms and computational software running with GPUs on Cloud.
Locations
Israel
Tuval St 40, Ramat Gan, 5252247, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Tuval St 40, Ramat Gan, 5252247, Israel
Nectin Therapeutics
Next-generation Immunotherapy Agents
Nectin Therapeutics is a biotechnology company devoted to transforming the lives of cancer patients by the development of next-generation immune-oncology (IO) therapies.
The company is dedicated to the development of novel therapeutic options for cancer patients. It is developing a diverse pipeline of targeted antibodies based on the nectin pathways. These antibodies overcome inhibitory pathways deployed by the tumors and allow immune cells to effectively destroy cancer cells. Additionally, based on the unique expression patterns of several nectin proteins, it develops CAR-T and -NK drivers that directly target tumor cells in various indications, including hard-to-treat cancers.
The company was established based on seminal research at the Hebrew University of Jerusalem and the University of Rijeka. Its technology addresses major escape mechanisms of current IO therapies through a diverse pipeline of novel monoclonal antibodies and antibody-drug-conjugates.
The company is dedicated to the development of novel therapeutic options for cancer patients. It is developing a diverse pipeline of targeted antibodies based on the nectin pathways. These antibodies overcome inhibitory pathways deployed by the tumors and allow immune cells to effectively destroy cancer cells. Additionally, based on the unique expression patterns of several nectin proteins, it develops CAR-T and -NK drivers that directly target tumor cells in various indications, including hard-to-treat cancers.
The company was established based on seminal research at the Hebrew University of Jerusalem and the University of Rijeka. Its technology addresses major escape mechanisms of current IO therapies through a diverse pipeline of novel monoclonal antibodies and antibody-drug-conjugates.
Locations
Israel
Givat Ram, Jerusalem, Israel
Offices Abroad
1 Bridge Plaza North, Fort Lee, NJ, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Givat Ram, Jerusalem, Israel
Offices Abroad
1 Bridge Plaza North, Fort Lee, NJ, USA
Opmed.AI
Operating Room Scheduling and Management
In an Operating Room (OR), every element is deeply interconnected, forming a complex and dynamic network. By viewing procedures as isolated blocks, conventional OR scheduling methods don't account for this intricate web of interdependencies.
Opmed utilizes AI and network science to illuminate these hidden connections. By viewing your OR as a dynamic network, the company empowers users to make strategic decisions, optimize resource allocation, predict disruptions, and adapt to rapidly shifting circumstances.
Opmed utilizes AI and network science to illuminate these hidden connections. By viewing your OR as a dynamic network, the company empowers users to make strategic decisions, optimize resource allocation, predict disruptions, and adapt to rapidly shifting circumstances.
Locations
Israel
Ramat Gan, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Ramat Gan, Israel
PhenoTA
Stealth Mode Startup
PhenoTA envisions a world where routine blood tests provide unparalleled insights into our health. By introducing novel technology and advanced AI capabilities applied to blood cells, the company is set to transform the landscape of medical decision making. That’s the future PhenoTA is creating, a one which will be impacting everyone.
Locations
Israel
Tel Aviv-Yafo, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Tel Aviv-Yafo, Israel
CombinAble.AI
Tailored Antibody Optimization
Combinable addresses a key challenge of trial-and-error in pharma development and manufacturing, by developing an in silico solution that optimizes properties concurrently. This approach seeks to identify multiple drug candidates that achieve a balanced profile across diverse characteristics, thus expediting and refining the drug discovery process.
Locations
Israel
Rehovot, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Rehovot, Israel
UltraSight
Cardiac Ultrasound with Real-time AI Guidance
UltraSight’s mission is to make diagnostic imaging more accessible by empowering medical professionals to successfully acquire timely and accurate cardiac ultrasound images anywhere. UltraSight's AI-driven software offers real-time guidance, making cardiac ultrasound accessible and efficient, which may lead to quicker diagnoses and improved patient care. In 2022, UltraSight won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most “innovative cardiac technology.”
Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. UltraSight’s software has FDA 510(k) Clearance, is UKCA and CE Marked, and has Israeli AMAR Clearance to assist medical professionals in performing cardiac ultrasound scans.
Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. UltraSight’s software has FDA 510(k) Clearance, is UKCA and CE Marked, and has Israeli AMAR Clearance to assist medical professionals in performing cardiac ultrasound scans.
Locations
Israel
Pinhas Sapir St 8, Ness Ziona, Israel
Offices Abroad
1 Broadway, Cambridge, MA 02142, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Pinhas Sapir St 8, Ness Ziona, Israel
Offices Abroad
1 Broadway, Cambridge, MA 02142, USA
NOGA Therapeutics
Gene Therapies for Severe and Chronic Illnesses
Noga Therapeutics is a gene therapy company focused on blood stem cell reprogramming to create transformative treatments for patients with severe and chronic illnesses. The company utilizes advanced lentiviral vector technology to reprogram blood stem cells, enabling targeted production of essential proteins within specific cells and tissues.
Noga’s therapeutic pipeline includes DopaGene for Parkinson’s disease, a novel gene therapy that induces sustained dopamine production in the brain. Additionally, the company is advancing treatments for X-linked Agammaglobulinemia (XLA), lysosomal storage diseases, and inflammatory bowel disease (IBD), targeting multiple conditions with significant unmet medical needs. Through these approaches, Noga Therapeutics aims to deliver durable, cell-targeted solutions that redefine treatment possibilities for complex diseases.
Noga’s therapeutic pipeline includes DopaGene for Parkinson’s disease, a novel gene therapy that induces sustained dopamine production in the brain. Additionally, the company is advancing treatments for X-linked Agammaglobulinemia (XLA), lysosomal storage diseases, and inflammatory bowel disease (IBD), targeting multiple conditions with significant unmet medical needs. Through these approaches, Noga Therapeutics aims to deliver durable, cell-targeted solutions that redefine treatment possibilities for complex diseases.
Locations
Israel
Pinhas Sapir St 3, Ness Ziona, 7403626, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Pinhas Sapir St 3, Ness Ziona, 7403626, Israel
Annabella Tech
Smart Breast Milk Pump
Annabella has developed a breast pump that mimics a baby's natural suckling motion. It pumps almost twice more milk than the leading brands on the market, and it is much more pleasant (feels almost like a baby). It was released in Israel in February 2023, taking between 5%-10% of the market each month ever since. Now The Annabella aims for the US market.
The company has its FDA and first patent approved (US and China).
The company has its FDA and first patent approved (US and China).
Locations
Israel
Kfar Saba, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Kfar Saba, Israel
PLAS-FREE
Innovative Blood Filtration Technology
Plas-Free is an Israel-based company specializing in the development of blood filtration systems. Its main product, ClearPlasma, is a single-use device designed to extract plasminogen, a key protein responsible for dissolving blood clots. By removing plasminogen from plasma units designated for transfusion, ClearPlasma enhances coagulation and promotes hemostasis. This technology has been proven in multiple clinical trials conducted in Israel and Europe.
In addition, Plas-Free is developing the Ammonia Adsorption Column-300 (AAPC-300), designed to reduce toxic accumulation in patients with liver failure. This technology is currently in pre-clinical trials. Plas-Free’s unique medical devices contribute to the Israeli medical ecosystem by integrating bio-convergence, combining chemistry, biology, and engineering to advance innovative healthcare solutions.
In addition, Plas-Free is developing the Ammonia Adsorption Column-300 (AAPC-300), designed to reduce toxic accumulation in patients with liver failure. This technology is currently in pre-clinical trials. Plas-Free’s unique medical devices contribute to the Israeli medical ecosystem by integrating bio-convergence, combining chemistry, biology, and engineering to advance innovative healthcare solutions.
Locations
Israel
Wadi el-Haj Street 13, Nazareth, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Wadi el-Haj Street 13, Nazareth, Israel
Mileutis
Bio-pharmaceuticals for Animal and Human Health
Mileutis is a bio-pharmaceutical company focused on the discovery, development, and commercialization of novel and biologically sourced, safe, and residual-free therapies for animal and human health.
Mileutis has developed a line of biopharmaceuticals that are revolutionizing the way in which farmers and veterinarians treat a wide range of diseases. Mileutis’ first products are comprised of peptides and specific protein fragments that have a positive impact on body functions and conditions that influence health. These peptides act through an immune-modulatory effect, enabling the management of infectious and chronic diseases without the use of antibiotics, thereby reducing the use of antibiotics in animal and human healthcare. This will assist in overcoming the global threat of antimicrobial resistance (AMR) generated by, among other things, the overuse of antibiotics.
The company's lead products are Imilac and Milac, which target the management, treatment, and prevention of mastitis in dairy cows. Mileutis's products aim to replace antibiotics in dairy farms, improve cow wellbeing, and provide additional and significant economic value to farmers by increasing milk yield and productivity.
Mileutis has developed a line of biopharmaceuticals that are revolutionizing the way in which farmers and veterinarians treat a wide range of diseases. Mileutis’ first products are comprised of peptides and specific protein fragments that have a positive impact on body functions and conditions that influence health. These peptides act through an immune-modulatory effect, enabling the management of infectious and chronic diseases without the use of antibiotics, thereby reducing the use of antibiotics in animal and human healthcare. This will assist in overcoming the global threat of antimicrobial resistance (AMR) generated by, among other things, the overuse of antibiotics.
The company's lead products are Imilac and Milac, which target the management, treatment, and prevention of mastitis in dairy cows. Mileutis's products aim to replace antibiotics in dairy farms, improve cow wellbeing, and provide additional and significant economic value to farmers by increasing milk yield and productivity.
Locations
Israel
Golda Me'ir Street 7, Ness Ziona, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Golda Me'ir Street 7, Ness Ziona, Israel
XRHealth
Virtual Clinic for Rehabilitation and Therapeutic Care
XRHealth is focused on bringing patient care into the virtual world. The company operates therapeutic care virtual rooms through the use of proprietary FDA- and CE-registered medical extended reality (XR) technology, including virtual and augmented reality.
XRHealth integrates immersive XR technology, licensed clinicians, and advanced data analytics on one platform, providing a comprehensive therapeutic care solution that enables patients to receive treatment from the comfort of home.
The company offers a variety of patent-pending solutions ranging from rehabilitation services to cognitive assessment and training to pain management. XRHealth works with several world-renowned U.S. healthcare providers, hospitals, and rehabilitation centers.
XRHealth integrates immersive XR technology, licensed clinicians, and advanced data analytics on one platform, providing a comprehensive therapeutic care solution that enables patients to receive treatment from the comfort of home.
The company offers a variety of patent-pending solutions ranging from rehabilitation services to cognitive assessment and training to pain management. XRHealth works with several world-renowned U.S. healthcare providers, hospitals, and rehabilitation centers.
Locations
Israel
Shoken 32, Tel Aviv-Yafo, Israel
Offices Abroad
200 Highland Ave, Needham, MA 02494, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Shoken 32, Tel Aviv-Yafo, Israel
Offices Abroad
200 Highland Ave, Needham, MA 02494, USA
Empathy
Digital Companion for Navigating Bereavement
Empathy's app helps families through the financial, legal, emotional, and logistical challenges of losing a loved one.
The Empathy app includes personalized task navigation, one place to securely save important documents, and real-time chat with loss experts. The app also automates processes related to estate management.
The Empathy app includes personalized task navigation, one place to securely save important documents, and real-time chat with loss experts. The app also automates processes related to estate management.
Locations
Israel
Ha-Arba'a Street 28, Tel Aviv-Yafo, Israel
Offices Abroad
27 E 28th St, New York, NY, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Ha-Arba'a Street 28, Tel Aviv-Yafo, Israel
Offices Abroad
27 E 28th St, New York, NY, USA
OurRitual
Skill-building App for Relationships
OurRitual has developed a relationship strengthening app that combines practical skill-building with guidance and attention from a human expert every step of the way. The company’s technology combines skill-building with one-on-one professional online support to help couples and individuals overcome relationship struggles and build better and stronger bonds in a way that fits the modern lifestyle. OurRitual is more accessible, flexible, and light than traditional therapy and is designed for the majority of couples who have issues that are not a huge crisis.
Locations
Israel
Tel Aviv-Yafo, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Tel Aviv-Yafo, Israel
Genoox
Genomic Data Management Platform
Genoox is a healthcare and technology company aiming to make clinical genetic sequencing more accessible. Using the companys cloud-based advanced framework encompassing purpose-built applications, users can easily manage the entire genetic sequencing process and create virtual genetic test modules providing plug-and-play options for the delivery of clinical actionable insights and disease diagnoses.
Driven by artificial intelligence technology, the companys product, Franklin, integrates data from published literature and publicly available population, disease, and sequence databases and employs machine learning to derive a prediction aggregation score and adjust the weights of ACMG classification criteria.
Genoox removes the final barrier to widespread adoption of clinical NGS, enabling personalized medicine for mainstream patients. Its platform is used in the diagnosis and treatment of genetic disorders and cancer, as well as new drug discovery and family planning.
Genoox aims to improve patient outcomes with increased accuracy and efficiency, enabling personalized medicine and patient-specific treatments.
Driven by artificial intelligence technology, the companys product, Franklin, integrates data from published literature and publicly available population, disease, and sequence databases and employs machine learning to derive a prediction aggregation score and adjust the weights of ACMG classification criteria.
Genoox removes the final barrier to widespread adoption of clinical NGS, enabling personalized medicine for mainstream patients. Its platform is used in the diagnosis and treatment of genetic disorders and cancer, as well as new drug discovery and family planning.
Genoox aims to improve patient outcomes with increased accuracy and efficiency, enabling personalized medicine and patient-specific treatments.
Locations
Israel
Tel Aviv-Yafo, Israel
Offices Abroad
550 California Avenue, Palo Alto, CA, USA
New York City, NY, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Tel Aviv-Yafo, Israel
Offices Abroad
550 California Avenue, Palo Alto, CA, USA
New York City, NY, USA
MilagroAI
Autonomous Medical Coding
Milagro is leading the change in automating medical coding processes. Its cutting-edge technology eliminates the challenges associated with down coding, denials and the growing shortage of medical coders. By leveraging the power of technology, Milagro enables organizations to meet increasing coding demands while maintaining high levels of accuracy
Locations
Israel
HaTa'asiya St 21, Ra'anana, Israel
Offices Abroad
500 Indigo Lane, Georgetown, Texas 78628, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
HaTa'asiya St 21, Ra'anana, Israel
Offices Abroad
500 Indigo Lane, Georgetown, Texas 78628, USA
AccuLine
Preventing the next Heart Attack
AccuLine was founded with the vision to save the lives of millions of people worldwide by preventing the next heart attack. AccuLine is developing CORA – an accurate, non-invasive, swift, and cost-effective examination for early detection of CAD, designed to replace the inaccurate, time-consuming, and labor-intensive stress test examinations.
Through a brief 4-minute evaluation of three vital signs - the heart's electrical activity, oxygen saturation levels, and respiratory phase, CORA automatically generates results, ensuring a seamless and efficient process. CORA has the potential to save the lives of millions of patients worldwide, while simultaneously decreasing health care-related costs.
AccuLine has received grants from Google and the Israeli Innovation Authority, and among its shareholders are Mayo Clinic, eHealth Ventures and Maccabi Healthcare Services.
Through a brief 4-minute evaluation of three vital signs - the heart's electrical activity, oxygen saturation levels, and respiratory phase, CORA automatically generates results, ensuring a seamless and efficient process. CORA has the potential to save the lives of millions of patients worldwide, while simultaneously decreasing health care-related costs.
AccuLine has received grants from Google and the Israeli Innovation Authority, and among its shareholders are Mayo Clinic, eHealth Ventures and Maccabi Healthcare Services.
Locations
Israel
Park Ofer, הפסגות 9, פתח תקווה, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Park Ofer, הפסגות 9, פתח תקווה, Israel
Unlimited Robotics
Customizable Service Robot for Diverse Environments
Unlimited Robotics develops multifunctional robots, focusing on their robot "Gary," designed for diverse tasks in healthcare, hospitality, and other industries. They offer a platform called Ra-Ya for developers to create custom applications for their robots, enhancing functionality. Their Orchestra system manages and operates robotics fleets, integrating with various IoT devices to monitor and analyze operations.
Locations
Israel
Tel Aviv-Yafo, Israel
Offices Abroad
12 Channel St, Boston, MA 02210, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Tel Aviv-Yafo, Israel
Offices Abroad
12 Channel St, Boston, MA 02210, USA
DigitalOwl
AI-powered Medical Record Summarization Platform
DigitalOwl develops a natural-language-processing solution for analyzing and summarizing medical records for the insurance industry. DigitalOwl's platform was developed exclusively for medical records and reviews records faster and more accurately than a manual review.
By extracting medical information from the records submitted to the platform, DigitalOwl provides a focused summary of medical data points with an easy-to-use navigation system. The report ensures users have the important, meaningful data points right at their fingertips in hours.
By extracting medical information from the records submitted to the platform, DigitalOwl provides a focused summary of medical data points with an easy-to-use navigation system. The report ensures users have the important, meaningful data points right at their fingertips in hours.
Locations
Israel
Ha-Shlosha Street 2, Tel Aviv-Yafo, Israel
Offices Abroad
30 Danforth Street, Portland, ME, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Ha-Shlosha Street 2, Tel Aviv-Yafo, Israel
Offices Abroad
30 Danforth Street, Portland, ME, USA
GaitBetter
Motor-Cognitive Gait Training & Fall Prevention
GaitBetter is a digital therapeutic platform specifically designed for gait rehabilitation, prevention of falls, and prediction of neurodegeneration. By adding virtual simulations to any existing treadmill, GaitBetter enables personalized motor-cognitive intervention, a new modality that was proven significantly more effective than alternatives. 22 peer-reviewed publications, +120 systems, +50 paying customers, and over 10,000 patients to date, are evidence of GaitBetter's cognitive-first approach.
Locations
Israel
Nevatim St 4, Petah Tikva, Israel
Offices Abroad
131 Rollins Ave # 4, Rockville, MD 20852, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Nevatim St 4, Petah Tikva, Israel
Offices Abroad
131 Rollins Ave # 4, Rockville, MD 20852, USA
CalmiGo
Drug-free Relief from Anxiety, Stress, and Panic Attacks
CalmiGo is a drug-free device designed to provide immediate relief during moments of anxiety and distress by regulating the user’s breathing patterns and senses, thereby alleviating symptoms on the spot.
CalmiGo uses three proven techniques to decrease stress hormone levels by enabling the body to quiet the stressful sympathetic nervous system while activating the calming parasympathetic nervous system through the use of personalized breathing regulation, multisensory stimulation, and soothing scents.
CalmiGo was developed by Dendro Technologies Inc.
CalmiGo uses three proven techniques to decrease stress hormone levels by enabling the body to quiet the stressful sympathetic nervous system while activating the calming parasympathetic nervous system through the use of personalized breathing regulation, multisensory stimulation, and soothing scents.
CalmiGo was developed by Dendro Technologies Inc.
Locations
Israel
Ha-Melakha St 45, Netanya, Israel
Offices Abroad
430 W 116th St, New York, NY 10027, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Ha-Melakha St 45, Netanya, Israel
Offices Abroad
430 W 116th St, New York, NY 10027, USA
SpliSense
RNA-based Treatment for Genetic Diseases
SpliSense is a clinical stage company developing transformative RNA-based treatments for unmet needs relating to diverse pulmonary diseases. Its treatment is based on clinically validated Antisense Oligonucleotide (ASO) technology, delivered non-invasively by inhalation to the lungs.
The company is focused on a variety of innovative therapies, in different development stages from discovery to IND.
Using an innovative approach, SpliSense aims to target the root cause of the disease, to overcome specific genetic mutations and modulate proteins expression and function.
The company recieved FDA approval for its lead ASO product, SPL84, for the treatment of patients with cystic fibrosis.
The company is focused on a variety of innovative therapies, in different development stages from discovery to IND.
Using an innovative approach, SpliSense aims to target the root cause of the disease, to overcome specific genetic mutations and modulate proteins expression and function.
The company recieved FDA approval for its lead ASO product, SPL84, for the treatment of patients with cystic fibrosis.
Locations
Israel
Kalman Ya'akov Man St, Jerusalem, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Kalman Ya'akov Man St, Jerusalem, Israel
Converge Bio
Generative AI Platform for Biological Engineering
Converge Bio is aiming is revolutionize biological R&D by creating a Generative AI platform for DNA, RNA, and protein sequences.
Locations
Israel
Daniel Frisch St, Tel Aviv-Yafo, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Daniel Frisch St, Tel Aviv-Yafo, Israel
Variantyx
Advanced Genomic Diagnostic Solutions
Variantyx is an award-winning, technology-driven molecular diagnostics lab that offers innovative solutions in the genetic disorders, reproductive health, and precision oncology markets. Its proprietary whole genome analysis platform provides unparalleled diagnostic capabilities, enhances personalized treatment recommendations, shortens the time to diagnosis, and reduces healthcare costs.
The company offers a wide variety of test options, ranging from targeted to comprehensive analyses. Targeted analyses focus on pre-curated panels of indication-relevant genes while comprehensive analyses consider all genes. All tests are performed on a whole genome platform. This makes it easy to start with a targeted analysis and automatically reflex up to a comprehensive analysis if the first test is non-diagnostic. No additional sample or sequencing is required.
The company offers a wide variety of test options, ranging from targeted to comprehensive analyses. Targeted analyses focus on pre-curated panels of indication-relevant genes while comprehensive analyses consider all genes. All tests are performed on a whole genome platform. This makes it easy to start with a targeted analysis and automatically reflex up to a comprehensive analysis if the first test is non-diagnostic. No additional sample or sequencing is required.
Locations
Israel
Chaim Levanon Street 55, Tel Aviv-Yafo, Israel
Offices Abroad
1671 Worcester Road, Framingham, MA 01701, United States
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Chaim Levanon Street 55, Tel Aviv-Yafo, Israel
Offices Abroad
1671 Worcester Road, Framingham, MA 01701, United States
Fijoya
Personalized, Employer-funded Health Benefits Platform
Fijoya is a health and wellness benefits platform that consolidates thousands of point solution services and products into a single, pay-per-use contract.
Employers choose a monthly stipend and we handle the end-to-end administration from selection to payment (and since you only pay for what is used, unspent funds return to your budget). Employees can shop for personalized health and wellness benefits - from lab tests to pet care, fitness, meditation, egg-freezing, and yoga - with a virtual corporate card.
Employers choose a monthly stipend and we handle the end-to-end administration from selection to payment (and since you only pay for what is used, unspent funds return to your budget). Employees can shop for personalized health and wellness benefits - from lab tests to pet care, fitness, meditation, egg-freezing, and yoga - with a virtual corporate card.
Locations
Israel
Totseret ha-Arets St 7, Tel Aviv-Yafo, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Totseret ha-Arets St 7, Tel Aviv-Yafo, Israel
Momentis Surgical
Robot-assisted Surgical Platform
Momentis Surgical aims to transform robotic-assisted surgery using proprietary technology. The company's Anovo Surgical System features humanoid-shaped miniature robotic arms with human dexterity, superhuman flexibility, and 360-degree articulation, providing exceptional access and maneuverability.
The Anovo Surgical System is an endoscopic instrument control system that is intended to assist in the accurate control of the Anovo Arms during single-site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures.
The Anovo Surgical System features unique robotic instrument ARMS that mimic the movement of the surgeon’s shoulder, elbow and wrist, offering high dexterity, multi-planar flexibility and unprecedented articulation. The ability to articulate the ARMS enables the transvaginal approach to benign gynecologic procedures and surgeons are able to use the familiar fundus to cervix technique without the need for multiple abdominal incisions. Anovo requires a much smaller footprint and costs significantly less than conventional robotic systems, making it possible for more hospitals and ambulatory surgery centers to acquire the system.
The company received FDA 510(k) clearance for its Anovo robotic surgical platform.
The Anovo Surgical System is an endoscopic instrument control system that is intended to assist in the accurate control of the Anovo Arms during single-site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures.
The Anovo Surgical System features unique robotic instrument ARMS that mimic the movement of the surgeon’s shoulder, elbow and wrist, offering high dexterity, multi-planar flexibility and unprecedented articulation. The ability to articulate the ARMS enables the transvaginal approach to benign gynecologic procedures and surgeons are able to use the familiar fundus to cervix technique without the need for multiple abdominal incisions. Anovo requires a much smaller footprint and costs significantly less than conventional robotic systems, making it possible for more hospitals and ambulatory surgery centers to acquire the system.
The company received FDA 510(k) clearance for its Anovo robotic surgical platform.
Locations
Israel
Yehadut Canada Street 3, Or Yehuda, Israel
Offices Abroad
5300 Northwest 33rd Avenue, Fort Lauderdale, FL, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Yehadut Canada Street 3, Or Yehuda, Israel
Offices Abroad
5300 Northwest 33rd Avenue, Fort Lauderdale, FL, USA
Predicta Med
Connecting the Dots of Undiagnosed Diseases
Predicta Med is a platform that enables early detection and intervention selection of autoimmune diseases. Its platform gives healthcare providers an AI-powered method for shortening the diagnostic process of identifying autoimmune diseases and by that could enhance provider’s efficiency, improve treatment effectiveness and patient's care. A process which typically takes more than four years and at least four different doctors can be shortened significantly using the platform.
Predicta Med’s deep learning engine aggregates EMR and claims data, and enriches and analyzes this data using state-of-the-art learning techniques. The platform discovers patients at risk of having an autoimmune disease and provides actionable insights to enable optimal intervention.
Predicta Med’s deep learning engine aggregates EMR and claims data, and enriches and analyzes this data using state-of-the-art learning techniques. The platform discovers patients at risk of having an autoimmune disease and provides actionable insights to enable optimal intervention.
Locations
Israel
Tuval St 40, Ramat Gan, 5252247, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Tuval St 40, Ramat Gan, 5252247, Israel
GyneCheck
Remote Female Care
Gynecheck is developing a novel, fully remote, home use gynecological platform for the prevention & treatment of gynecological diseases.
The platform enables affordable remote care solutions-Anywhere, Anytime.
The platform enables affordable remote care solutions-Anywhere, Anytime.
Locations
Israel
Herzliya, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Herzliya, Israel
Magnisity
Surgical Guidance Platform
Magnisity is developing a cutting-edge surgical guidance platform, designed to overcome some of the toughest challenges in minimally invasive medicine. The company is empowering surgeons to go beyond what is humanly possible and set the future standards of endoluminal interventions.
To do this, Magnisity is inventing algorithms, designing hardware, developing software, crafting precise mechanics and creating beautiful engineering.
To do this, Magnisity is inventing algorithms, designing hardware, developing software, crafting precise mechanics and creating beautiful engineering.
Locations
Israel
Yoni Netanyahu St 5, Or Yehuda, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Yoni Netanyahu St 5, Or Yehuda, Israel
Laminate Medical Technologies
Implanted Device for Renal Vascular Procedures in Dialysis Patients
Laminate Medical Technologies was founded to develop solutions for the most significant challenges preventing fistula use in dialysis patients.
Laminate’s flagship product, VasQ External Support, was designed to address the high rate of primary fistula failure and repeat procedures experienced by hemodialysis patients. Primary fistula failure rates have been estimated as high as 60% with most patients requiring frequent additional procedures to make the fistula functional.
However, clinical results have demonstrated fistulas treated with VasQ have a significantly greater probability for success in becoming functional without the need for additional procedures.
VasQ was granted FDA De Novo approval and is available for sale in the United States, Singapore, Europe, Africa and the UK.
Laminate’s flagship product, VasQ External Support, was designed to address the high rate of primary fistula failure and repeat procedures experienced by hemodialysis patients. Primary fistula failure rates have been estimated as high as 60% with most patients requiring frequent additional procedures to make the fistula functional.
However, clinical results have demonstrated fistulas treated with VasQ have a significantly greater probability for success in becoming functional without the need for additional procedures.
VasQ was granted FDA De Novo approval and is available for sale in the United States, Singapore, Europe, Africa and the UK.
Locations
Israel
Raoul Wallenberg Street 24, Tel Aviv-Yafo, Israel
Offices Abroad
411 Lafayette Street, New York, NY, USA
Europaplatz 2, Berlin, Berlin, Germany
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Raoul Wallenberg Street 24, Tel Aviv-Yafo, Israel
Offices Abroad
411 Lafayette Street, New York, NY, USA
Europaplatz 2, Berlin, Berlin, Germany
Foresee Genomics
Cancer Genomics Diagnostics
Foresee Genomics is developing a DNA testing system for cancer patients that combines molecular biology and computational analysis. The companys tests are designed to provide physicians with the genetic data needed for determining treatment options. Foresee Genomics procedure requires low-cost equipment and is intended to be performed at the point of care, in hospitals or local clinics.
The nanopore sequencing platform is significantly inexpensive in comparison to all other NGS platform. The combined system of Foresee Genomic and the nanopore sequencer is an end-to-end solution for genomic diagnostics which is accurate and affordable.
The nanopore sequencing platform is significantly inexpensive in comparison to all other NGS platform. The combined system of Foresee Genomic and the nanopore sequencer is an end-to-end solution for genomic diagnostics which is accurate and affordable.
Locations
Israel
Netiv ha-Or 1, Haifa, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Netiv ha-Or 1, Haifa, Israel
FEMSelect
Treatment for Pelvic Floor Ligament Fixation
FEMSelect is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation.
The EnPlace procedure takes approximately 30 minutes. Its patented delivery system enables precise guidance, insertion, and deployment of the anchor unit, which is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization.
EnPlace is FDA cleared and CE marked. The device is a combination of a Nitinol-based anchor, surgical sutures, and an innovative attachment method, and the surgery is conducted with no deep dissection or mesh. EnPlace has been tested in a human trial in Israel and is protected by global and U.S. patents.
The EnPlace procedure takes approximately 30 minutes. Its patented delivery system enables precise guidance, insertion, and deployment of the anchor unit, which is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization.
EnPlace is FDA cleared and CE marked. The device is a combination of a Nitinol-based anchor, surgical sutures, and an innovative attachment method, and the surgery is conducted with no deep dissection or mesh. EnPlace has been tested in a human trial in Israel and is protected by global and U.S. patents.
Locations
Israel
HaMa'ayan Street 2, Modi'in-Maccabim-Re'ut, Israel
Offices Abroad
7 Creek Bend Court, Newark, DE, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
HaMa'ayan Street 2, Modi'in-Maccabim-Re'ut, Israel
Offices Abroad
7 Creek Bend Court, Newark, DE, USA
Sherman Diagnostics
Pathogen Detection Technology
Sherman Diagnostics has developed a diagnostic technology designed to detect pathogens using any biological sample. The company’s technology can be used for rapid testing of infectious diseases such as coronavirus economically and efficiently, enabling users to affordably detect DNA/RNA-based pathogens.
Locations
Israel
Zarhin St 13, Ra'anana, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Zarhin St 13, Ra'anana, Israel
Intuition Robotics
Maker of ElliQ, the AI companion for happier, healthier aging
ntuition Robotics is the company behind ElliQ, an award-winning AI-powered companion robot that helps older adults age independently by reducing loneliness, promoting wellness, and keeping them connected to family and community.
Designed specifically for older adults, ElliQ delivers proactive, personalized interactions based on each person’s routines, preferences, and goals. Through natural conversation, body language, and contextual awareness, ElliQ offers cognitive and physical wellness support, meaningful companionship, and daily motivation—fostering long-term engagement and behavioral change.
At the core of ElliQ is a proprietary technology stack with a strong intellectual property foundation. Intuition Robotics holds 12 U.S. patents, many in the field of artificial intelligence and human-machine interaction, with more than 20 additional patents pending.
The company partners with state governments, managed care organizations, and senior care providers to bring ElliQ to thousands of older adults across the U.S., including statewide partnerships in New York, impactful programs in Florida, and additional healthcare partnerships.
Designed specifically for older adults, ElliQ delivers proactive, personalized interactions based on each person’s routines, preferences, and goals. Through natural conversation, body language, and contextual awareness, ElliQ offers cognitive and physical wellness support, meaningful companionship, and daily motivation—fostering long-term engagement and behavioral change.
At the core of ElliQ is a proprietary technology stack with a strong intellectual property foundation. Intuition Robotics holds 12 U.S. patents, many in the field of artificial intelligence and human-machine interaction, with more than 20 additional patents pending.
The company partners with state governments, managed care organizations, and senior care providers to bring ElliQ to thousands of older adults across the U.S., including statewide partnerships in New York, impactful programs in Florida, and additional healthcare partnerships.
Locations
Israel
HaYetsira Street 3, Ramat Gan, Israel
Offices Abroad
460 Natoma St, San Francisco, California, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
HaYetsira Street 3, Ramat Gan, Israel
Offices Abroad
460 Natoma St, San Francisco, California, USA
Rapid Medical
Neurovascular Devices
Rapid Medical develops safe and effective neurovascular medical devices designed to benefit patients while meeting the needs of physicians. Its products include distal access catheters and adjustable remodeling mesh for microcatheters. The company is committed to advancing patient care by providing reliable, easy-to-use, high-quality products supported by clinical data.
Rapid Medicals Tigertriever 13 is a CE-marked small-profile stentriever designed to safely retrieve clots from intracranial vessels of 1 mm to 2.5 mm. Its Comaneci device is an FDA 510(k)-cleared adjustable, fully visible aneurysm-remodeling device intended to act as a temporary bridge to aid in the coiling process and minimize the risk of coil protrusion or prolapse.
The companys Drivewire (named Columbus outside the U.S.) is an FDA-cleared guidewire with a steerable distal tip that handles complex anatomical turns with ease. With Drivewire, physicians control the direction and shape of the guidewires tip while it is inside the vessel, precisely navigating the neuro and peripheral vasculature. This intravascular steering provides access to difficult anatomical locations, increasing the physicians ability to treat vascular diseases with less invasive interventional approaches.
Rapid Medicals Tigertriever 13 is a CE-marked small-profile stentriever designed to safely retrieve clots from intracranial vessels of 1 mm to 2.5 mm. Its Comaneci device is an FDA 510(k)-cleared adjustable, fully visible aneurysm-remodeling device intended to act as a temporary bridge to aid in the coiling process and minimize the risk of coil protrusion or prolapse.
The companys Drivewire (named Columbus outside the U.S.) is an FDA-cleared guidewire with a steerable distal tip that handles complex anatomical turns with ease. With Drivewire, physicians control the direction and shape of the guidewires tip while it is inside the vessel, precisely navigating the neuro and peripheral vasculature. This intravascular steering provides access to difficult anatomical locations, increasing the physicians ability to treat vascular diseases with less invasive interventional approaches.
Locations
Israel
Yokne'am Illit, Israel
Offices Abroad
Westendstrae 21, Frankfurt, Germany
1355 Shotgun Road, Sunrise, Florida, USA
United Kingdom
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Yokne'am Illit, Israel
Offices Abroad
Westendstrae 21, Frankfurt, Germany
1355 Shotgun Road, Sunrise, Florida, USA
United Kingdom
Remepy
Pioneering Hybrid Drugs
Remepy is pioneering hybrid drugs, and redefining combination therapy. Its mission is to bring better personalized care to patients.
Remepy’s Digital molecules are mobile applications designed for hybrid drug experiences, each containing a unique digital treatment protocol. Its Digital molecules include digitized, standardized, evidence-based interventions, designed to enhance brain plasticity and connectivity, balance the immune system, and drive behavioral changes. The company addresses disease end-points as well as side-effects and disease comorbidities.
Remepy partners with pharma companies to bring Hybrid Drugs to market that will combine Remepy’s Digital Molecule and traditional drug components.
Remepy’s Digital molecules are mobile applications designed for hybrid drug experiences, each containing a unique digital treatment protocol. Its Digital molecules include digitized, standardized, evidence-based interventions, designed to enhance brain plasticity and connectivity, balance the immune system, and drive behavioral changes. The company addresses disease end-points as well as side-effects and disease comorbidities.
Remepy partners with pharma companies to bring Hybrid Drugs to market that will combine Remepy’s Digital Molecule and traditional drug components.
Locations
Israel
Ramat Gan, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Ramat Gan, Israel
Cordio Medical
Medical Speech-processing Platform
Cordio Medical provides medical grade, groundbreaking solutions to monitor several health conditions by analyzing voice samples recorded in a simple smartphone app backed by sophisticated and proprietary algorithms allowing near real-time monitoring and early detection of condition deterioration.
Using only patient speech, sampled via mobile device, the Cordio HearO™ can sense fluid accumulation related to CHF and alert healthcare professionals in real-time. This is the only non-invasive, easy to use medical grade, CHF monitoring device that offers patients and caretakers peace of mind and a true sense of control.
Cordio Med's technologies are based on true speech signal processing technology, unique to each patient, augmented with machine learning capabilities. The system is patient-tailored, and is constantly learning the patient’s voice and providing personalized, seamless and effortless monitoring.
Cordio’s goal is to identify and mitigate condition worsening by helping physicians prevent patient deterioration and hospitalization while keeping the patient involved and informed.
Using only patient speech, sampled via mobile device, the Cordio HearO™ can sense fluid accumulation related to CHF and alert healthcare professionals in real-time. This is the only non-invasive, easy to use medical grade, CHF monitoring device that offers patients and caretakers peace of mind and a true sense of control.
Cordio Med's technologies are based on true speech signal processing technology, unique to each patient, augmented with machine learning capabilities. The system is patient-tailored, and is constantly learning the patient’s voice and providing personalized, seamless and effortless monitoring.
Cordio’s goal is to identify and mitigate condition worsening by helping physicians prevent patient deterioration and hospitalization while keeping the patient involved and informed.
Locations
Israel
Yehonatan Netanyahu St 6, Or Yehuda, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Yehonatan Netanyahu St 6, Or Yehuda, Israel
CytoReason
Machine Learning for Data-driven Target Discovery and Drug Development
CytoReason is a technology company developing a computational model of the human body that simulates human disease on a cellular level, minimizes the need for animal trials, and makes human trials more focused and accurate.
With CytoReason's proprietary database and AI-led platform, pharmaceutical and biotechnology companies can make data-driven decisions quickly and cost effectively. To date, five of the world’s top ten pharma companies use CytoReason’s technology to identify new opportunities, shorten trial phases, reduce development costs, and increase the likelihood of drug approval.
With CytoReason's proprietary database and AI-led platform, pharmaceutical and biotechnology companies can make data-driven decisions quickly and cost effectively. To date, five of the world’s top ten pharma companies use CytoReason’s technology to identify new opportunities, shorten trial phases, reduce development costs, and increase the likelihood of drug approval.
Locations
Israel
Derech Menachem Begin 132, Tel Aviv-Yafo, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Derech Menachem Begin 132, Tel Aviv-Yafo, Israel
DenovAI Biotech
Dynamic Protein Design
DenovAI is developing foundational technology platforms that can design proteins de novo - completely from scratch.
The company is starting the journey to design next generation therapeutics like high-affinity antibodies, small protein and peptide biologics, and diagnostic reporters - all tailored to bind to their specific targets.
Its AI-based platform for rapid de novo antibody discovery will design high-affinity binders to epitopes of choice, reduce the discovery process from months to days and broaden the scope of therapy to many more diseases.
The platform for de novo protein design can design bespoke high-affinity binders for targets of choice – unlocking many applications in biologics and diagnostics.
The company is starting the journey to design next generation therapeutics like high-affinity antibodies, small protein and peptide biologics, and diagnostic reporters - all tailored to bind to their specific targets.
Its AI-based platform for rapid de novo antibody discovery will design high-affinity binders to epitopes of choice, reduce the discovery process from months to days and broaden the scope of therapy to many more diseases.
The platform for de novo protein design can design bespoke high-affinity binders for targets of choice – unlocking many applications in biologics and diagnostics.
Locations
Israel
4 Oppenheimer Building B 17th Floor, Rehovot, 7670104, Israel
Offices Abroad
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
4 Oppenheimer Building B 17th Floor, Rehovot, 7670104, Israel
Valera Health
Comprehensive Behavioral Health Solution
Valera Health offers personalized mental health services combining meditation, therapy, and medications wrapped around with technology.
The company helps organizations expand access to behavioral healthcare. It provides a comprehensive behavioral health solution for employers that gives employees fast access to high-quality mental healthcare.
The Valera Health app keeps patients connected to their care team. Using the app, patients can reach out to their health coach or therapist through a secure chat, access a digital library of wellness and meditation programs, and chat face to face with clinicians through an in-app video call. The company also partners with some insurance carriers (such as CDPHP) to offer services directly to their members.
Valera Health therapists are highly trained, licensed mental health professionals with expertise in a variety of evidence-based therapy models, including cognitive behavioral therapy, psychoanalysis, mindfulness, and trauma-informed care.
The company helps organizations expand access to behavioral healthcare. It provides a comprehensive behavioral health solution for employers that gives employees fast access to high-quality mental healthcare.
The Valera Health app keeps patients connected to their care team. Using the app, patients can reach out to their health coach or therapist through a secure chat, access a digital library of wellness and meditation programs, and chat face to face with clinicians through an in-app video call. The company also partners with some insurance carriers (such as CDPHP) to offer services directly to their members.
Valera Health therapists are highly trained, licensed mental health professionals with expertise in a variety of evidence-based therapy models, including cognitive behavioral therapy, psychoanalysis, mindfulness, and trauma-informed care.
Locations
Israel
Ya'akov Schreiboim St 26, Jerusalem, Israel
Offices Abroad
134 North 4th Street, Brooklyn, NY, USA
Primary sector
Total funding
Funding stage
Number of employees
Founded
Israel Offices
Ya'akov Schreiboim St 26, Jerusalem, Israel
Offices Abroad
134 North 4th Street, Brooklyn, NY, USA